Pharmaceuticals, Biotechnology and Life Sciences
Gilead get’s authorization of emergency use of Remdesivir to treat hospitalized patients with severe COVID-19 disease in the United States.
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the retirement of Bruce Given, M.D., Arrowhead’s chief operating officer and…
Revance, Mylan Biosimilar to Botox postpon program decision to aftr April
ST. PAUL, Minn.–(BUSINESS WIRE)–3M today announced that it has completed the sale of substantially all of its drug delivery business…
Moderna has engaged with Lonza to work on its novel coronavirus vaccine, with a goal to enable manufacturing of up to 1 billion doses per year, noting that technology transfer is expected to begin in June 2020.
Shionogis’ Fetcroja (cefiderocol) in the end of April 2020 received European Commission (EC) marketing authorisation for the treatment of infections due to aerobic Gram-negative bacteria in adults with limited treatment options.
ALBANY, N.Y.–(BUSINESS WIRE)–AMRI today announced its ongoing commitment to do its part in support of public health needs amidst the…
SEATTLE–(BUSINESS WIRE)–For the full text of the press release, please visit here. Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced…
SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today…